(Q37419250)

20 August 2017

1 reference

title

Current treatments of chronic immune-mediated demyelinating polyneuropathies (English)

1 reference

20 August 2017

Thomas H Brannagan

1

1 reference

20 August 2017

1 May 2009

1 reference

20 August 2017

1 reference

20 August 2017

39

1 reference

20 August 2017

5

1 reference

20 August 2017

563-578

1 reference

Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria

20 August 2017

1 reference

Intravenous gammaglobulin (IVIg) for treatment of CIDP and related immune-mediated neuropathies

21 January 2018

1 reference

Complications of intravenous immune globulin treatment in neurologic disease

21 January 2018

1 reference

Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia

21 January 2018

1 reference

Acute renal insufficiency and cerebral infarction during high-dose intravenous immunoglobulin therapy

21 January 2018

1 reference

Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases

21 January 2018

1 reference

Intravenous immune globulin therapy for neurologic diseases

21 January 2018

1 reference

Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy

21 January 2018

1 reference

Facial vasculitic rash associated with intravenous immunoglobulin.

21 January 2018

1 reference

Distal acquired demyelinating symmetric neuropathy

21 January 2018

1 reference

Sustained remission of CIDP associated with Evans syndrome

21 January 2018

1 reference

Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases.

21 January 2018

1 reference

Chronic inflammatory demyelinating polyradiculoneuropathy: unusual clinical features and therapeutic responses.

21 January 2018

1 reference

Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors

21 January 2018

1 reference

Acute renal failure resulting from intravenous immunoglobulin therapy

21 January 2018

1 reference

The pathogenesis of CIDP: rationale for treatment with immunomodulatory agents

21 January 2018

1 reference

Interferon beta-1a as an investigational treatment for CIDP.

21 January 2018

1 reference

Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Clinical and laboratory characteristics associated with improvement

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MUS.21277

1 reference

20 August 2017

1 reference

PubMed ID

19301378